These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. Rask E, Walker BR, Söderberg S, Livingstone DE, Eliasson M, Johnson O, Andrew R, Olsson T. J Clin Endocrinol Metab; 2002 Jul; 87(7):3330-6. PubMed ID: 12107245 [Abstract] [Full Text] [Related]
8. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure. Homma M, Tanaka A, Hino K, Takamura H, Hirano T, Oka K, Kanazawa M, Miwa T, Notoya Y, Niitsuma T, Hayashi T. Metabolism; 2001 Jul; 50(7):801-4. PubMed ID: 11436185 [Abstract] [Full Text] [Related]
18. The prevalence of impaired glucose regulation in psychiatric patients with sleep disorders and its relationship with altered hypothalamopituitary-adrenal and hypothalamopituitary-thyroid axis activity. Li J, Sun X, Yu Y. Sleep Med; 2013 Jul; 14(7):662-7. PubMed ID: 23719477 [Abstract] [Full Text] [Related]
19. Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes. Jang C, Obeyesekere VR, Dilley RJ, Krozowski Z, Inder WJ, Alford FP. J Clin Endocrinol Metab; 2007 Aug; 92(8):3314-20. PubMed ID: 17519316 [Abstract] [Full Text] [Related]